Developer docs
API playgroundTry for free, no card

Search company profiles

Signifeye

Full company profile

uuid009f7ff

Namestring
Signifeye
Legal namestring
SIGNIFEYE – Eqiris N.V.
Websiteurl
signifeye.be
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Signifeye is a Belgian ophthalmology platform that consolidates independent eye-care practices under a single corporate umbrella (legal entity Eqiris N.V.), operating 9 clinics across 15 locations in Belgium's Flanders region and Brussels. Founded in 2019 around Oogcentrum Medipolis (Dr. Erik Mertens), the group has progressively acquired independent ophthalmology practices through a buy-and-build strategy, growing to include Brussels Eye Doctors, Eyecenter Oogartsen, Oogartsencentrum ZW-Vlaanderen, Oogartsenpraktijk Lier, Oogkliniek Brasschaat, Brussels Eye Center, Oogartsen Regio Limburg, and Oogcentrum Brugge. The platform serves general public patients and self-pay elective vision correction candidates across the full ophthalmology spectrum: cataract surgery, refractive surgery (SMILE-KLeX laser via Zeiss Visumax 800, ICL, lens replacement), glaucoma management, retinal disease, corneal disorders, pediatric ophthalmology, oculoplastics, and dry-eye therapy.

The group's core technology is advanced ophthalmic hardware rather than software platforms: Zeiss Visumax 800 femtosecond lasers enabling SMILE-KLeX lenticule extraction (notably extended to hyperopia by Dr. Fernand De Wilde), ICL implantable collamer lens systems, diagnostic imaging for retina/cornea/glaucoma, and IPL therapy for dry eye. Member clinics retain local branding and physician leadership while sharing cross-clinic medical knowledge via Synergy events, joint congress participation (OB, ESCRS, AECOS, Rockmed Academy), and a documented research record including a bilateral same-day ICL publication in the Journal of Refractive Surgery and ISO 9001:2015 certification at Brussels Eye Doctors.

Signifeye monetizes clinical services through consultation fees, diagnostics, and surgical procedures (both insured via Belgium's INAMI/RIZIV system and self-pay for elective refractive work), with pricing held at the clinic level rather than publicly disclosed. Distribution is purely direct-to-consumer via owned clinic locations and physician referrals. In December 2025, EssilorLuxottica announced the acquisition of Signifeye as part of its expansion into medical eye care, integrating the group into the wider Optegra international ophthalmology network (UK, Netherlands, Central Europe) with closing expected in Q1 2026.

Short descriptiontext

Belgian ophthalmology platform operating nine clinics across fifteen locations in Flanders and Brussels. Founded in 2019, Signifeye consolidates independent eye practices through buy-and-build, offering cataract, refractive, glaucoma, and retinal care. Now being acquired by EssilorLuxottica.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAntwerp, Belgium
HQ citystring
Antwerp
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices15 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ophthalmology services, eye care clinics, refractive surgery, cataract treatment, laser vision correction
Industry4 codes
PRIMARYHLAKAKAC
Ophthalmology Clinics (Medical & Surgical Eye Care)
SECONDARYHLAKAKAB
Optometry Clinics (Primary Eye Care)
SECONDARYHLAKAKAO
Ambulatory Surgery Centers (Ophthalmic/Outpatient Eye Surgery)
SECONDARYHLAKAKAE
Retina & Vitreous Specialists
NAICS code1 code
  • Offices of Optometrists62132
SIC code1 code
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Ophthalmology Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Ophthalmology Clinical Services
TypeProfessional Services
Description

Signifeye generates revenue through ophthalmology consultation fees, diagnostic services, and surgical procedures across its network of clinics. Revenue is derived from patient consultations, cataract surgery, refractive procedures (SMILE, ICL, lens exchange), glaucoma treatment, retinal procedures, and cosmetic eyelid surgery. The group is expanding its footprint through acquisitions to increase recurring revenue streams from ophthalmology services.

signifeye.be
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Signifeye operates a network of 9 Belgian ophthalmology clinics on 15 locations, providing comprehensive eye care from routine consultations and diagnostics to advanced surgical procedures. Core services include cataract surgery, refractive surgery (SMILE-KLeX laser vision correction, ICL implantation, lens replacement), glaucoma diagnosis and treatment, retinal and corneal disease management, pediatric ophthalmology, oculoplastic/eyelid surgery, and dry-eye therapy. The group also acts as a buy-and-build platform that integrates independent eye clinics into the network while preserving their local brand identity.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • First hyperopic SMILE procedure in Belgium and the Netherlands performed by Dr. Fernand De Wilde at Eyecenter, marking a world-first achievement in refractive surgery.
+2 more records
Product overview1 text field

Signifeye is a network of ophthalmology clinics in Belgium, operating 9 clinics across 15 locations. As part of the international Optegra group (owned by EssilorLuxottica), Signifeye provides comprehensive eye care services through its member clinics. The network includes specialized clinics offering cataract surgery, refractive surgery (including SMILE laser treatments, ICL lens implantation, and lens replacement), retinal treatments, glaucoma care, corneal treatments, pediatric ophthalmology, and general eye care. Member clinics retain their individual identities while benefiting from shared knowledge, advanced technologies, and collaborative expertise across the network.

Product and service12 records
1Signifeye Ophthalmology Clinic Network
CategoryOphthalmology clinic network
Description

A network of 9 ophthalmology clinics on 15 locations across Belgium that delivers comprehensive eye care — from routine consultations and diagnostics to cataract surgery, refractive surgery, glaucoma, retina, cornea, pediatric ophthalmology, oculoplastic and dry-eye treatments — under a unified quality framework while preserving each clinic's local identity.

2SMILE-KLeX Laser Vision Correction
CategoryRefractive surgery
Description

Advanced refractive surgery using the Zeiss Visumax 800 femtosecond laser to create and remove a precise corneal lenticule through a 2.5 mm incision, reshaping the cornea to correct myopia or, under SMILE-KLeX, hyperopia (with or without astigmatism).

3Circle Post Hyperopic SMILE Pro
CategoryRefractive surgery
Description

Next-generation SMILE-KLeX technique for hyperopia incorporating a Circle component, enabling treatment of farsightedness in patients aged 20-50 with hyperopia from +1 to +5 diopters, potentially combined with astigmatism.

4Oogcentrum Medipolis (Antwerp)
CategoryMember clinic
Description

Eye clinic in Antwerp founded by Dr. Erik Mertens, the first centre to join Signifeye in 2019; offers treatments to replace glasses and contact lenses, dry-eye treatment and other ophthalmology services for adult patients.

5Oogartsen Regio Limburg (Maasmechelen, Hasselt-Kiewit, Diepenbeek)
CategoryMember clinic
Description

Multi-site ophthalmology practice across the Limburg region focusing on retinal diseases, contact lenses, low vision, eye prosthetics, dry eyes with IPL therapy and myopia control therapy.

6Oogcentrum Brugge
CategoryMember clinic
Description

Bruges-based eye clinic with four doctors and seven staff, specializing in medical retina, eyelid surgery, tear duct surgery and general eye diseases.

7Brussels Eye Doctors
CategoryMember clinic
Description

Brussels eye clinic specializing in corneal disease diagnosis and treatment, strabismus, pediatric eye diseases, tear duct disorders and retinal diseases and surgery; ISO 9001:2015 certified by Lloyd's Register Quality Assurance since June 2024.

8Oogartsencentrum ZW-Vlaanderen & Kortrijk-West
CategoryMember clinic
Description

Ophthalmology center with locations in Harelbeke and Kortrijk-Bissegem, founded by Dr. Frank Kesteloot; a team of six ophthalmologists and four staff specializing in corneal and retinal disease (Kortrijk-West branch opened in 2024).

9Oogartsenpraktijk Lier
CategoryMember clinic
Description

Lier-based ophthalmology practice founded by Dr. May Dieltiens, covering refractive surgery, strabismus and amblyopia, retinal abnormalities, glaucoma and corneal abnormalities.

10Eyecenter Oogartsen (Sint-Martens-Latem, Eeklo, Merelbeke, Gavere)
CategoryMember clinic
Description

Large multi-site ophthalmology practice with eight ophthalmologists across four locations, founded by Dr. Fernand De Wilde; specializes in refractive surgery (SMILE laser, ICL lenses, lens exchange), cataract surgery, dry eyes, eyelid surgery, strabismus and age-related macular degeneration.

11Oogkliniek Brasschaat
CategoryMember clinic
Description

Brasschaat-based eye clinic founded by Dr. Ann Haustermans, with five ophthalmologists and seven staff providing eye care to adults and children, including consultations, treatments, cataract surgery, refractive surgery and cosmetic eyelid surgery.

12Brussels Eye Center
CategoryMember clinic
Description

Brussels eye clinic led by Dr. Jean Assaf with nine ophthalmologists, offering comprehensive eye care across general eye disease, cataracts, refractive surgery (laser, ICL, lens replacement), glaucoma, corneal disorders, strabismus, pediatric eye diseases, eyelid corrections, tear duct problems and retinal surgery.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-01
Description

Signifeye is an integral part of Optegra, an international ophthalmology group with operations in the United Kingdom, the Netherlands, and several Central European countries. Optegra itself is owned by EssilorLuxottica. The partnership enables knowledge sharing across borders, access to best practices, shared technology investments, and a unified quality framework for clinical excellence.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries9 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Signifeye

Ophthalmology Servicessignifeye.be

Belgian ophthalmology platform operating nine clinics across fifteen locations in Flanders and Brussels. Founded in 2019, Signifeye consolidates independent eye practices through buy-and-build, offering cataract, refractive, glaucoma, and retinal care. Now being acquired by EssilorLuxottica.

What Signifeye does

Signifeye is a Belgian ophthalmology platform that consolidates independent eye-care practices under a single corporate umbrella (legal entity Eqiris N.V.), operating 9 clinics across 15 locations in Belgium's Flanders region and Brussels. Founded in 2019 around Oogcentrum Medipolis (Dr. Erik Mertens), the group has progressively acquired independent ophthalmology practices through a buy-and-build strategy, growing to include Brussels Eye Doctors, Eyecenter Oogartsen, Oogartsencentrum ZW-Vlaanderen, Oogartsenpraktijk Lier, Oogkliniek Brasschaat, Brussels Eye Center, Oogartsen Regio Limburg, and Oogcentrum Brugge. The platform serves general public patients and self-pay elective vision correction candidates across the full ophthalmology spectrum: cataract surgery, refractive surgery (SMILE-KLeX laser via Zeiss Visumax 800, ICL, lens replacement), glaucoma management, retinal disease, corneal disorders, pediatric ophthalmology, oculoplastics, and dry-eye therapy.

The group's core technology is advanced ophthalmic hardware rather than software platforms: Zeiss Visumax 800 femtosecond lasers enabling SMILE-KLeX lenticule extraction (notably extended to hyperopia by Dr. Fernand De Wilde), ICL implantable collamer lens systems, diagnostic imaging for retina/cornea/glaucoma, and IPL therapy for dry eye. Member clinics retain local branding and physician leadership while sharing cross-clinic medical knowledge via Synergy events, joint congress participation (OB, ESCRS, AECOS, Rockmed Academy), and a documented research record including a bilateral same-day ICL publication in the Journal of Refractive Surgery and ISO 9001:2015 certification at Brussels Eye Doctors.

Signifeye monetizes clinical services through consultation fees, diagnostics, and surgical procedures (both insured via Belgium's INAMI/RIZIV system and self-pay for elective refractive work), with pricing held at the clinic level rather than publicly disclosed. Distribution is purely direct-to-consumer via owned clinic locations and physician referrals. In December 2025, EssilorLuxottica announced the acquisition of Signifeye as part of its expansion into medical eye care, integrating the group into the wider Optegra international ophthalmology network (UK, Netherlands, Central Europe) with closing expected in Q1 2026.

Signifeye firmographics

Firmographics
Name
Signifeye
Legal name
SIGNIFEYE – Eqiris N.V.
Website
https://signifeye.be
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
Belgian ophthalmology platform operating nine clinics across fifteen locations in Flanders and Brussels. Founded in 2019, Signifeye consolidates independent eye practices through buy-and-build, offering cataract, refractive, glaucoma, and retinal care. Now being acquired by EssilorLuxottica.
Ownership category
akta.pro rank

Signifeye industry classification

Industry
Product category
Ophthalmology Services
NAICS
Offices of Optometrists (62132)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro industry
PRIMARYHLAKAKAC
Ophthalmology Clinics (Medical & Surgical Eye Care)
SECONDARYHLAKAKAB
Optometry Clinics (Primary Eye Care)
SECONDARYHLAKAKAO
Ambulatory Surgery Centers (Ophthalmic/Outpatient Eye Surgery)
SECONDARYHLAKAKAE
Retina & Vitreous Specialists

Keywords

  • Ophthalmology services
  • Eye care clinics
  • Refractive surgery
  • Cataract treatment
  • Laser vision correction

Where Signifeye is headquartered

Location

Headquarters

HQ city
Antwerp
HQ country
Belgium
HQ region
Europe

Offices15 records

Markets served

Signifeye business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Ophthalmology Clinical Services: Signifeye generates revenue through ophthalmology consultation fees, diagnostic services, and surgical procedures across its network of clinics. Revenue is derived from patient consultations, cataract surgery, refractive procedures (SMILE, ICL, lens exchange), glaucoma treatment, retinal procedures, and cosmetic eyelid surgery. The group is expanding its footprint through acquisitions to increase recurring revenue streams from ophthalmology services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Signifeye product offering

Product offering

Core offering

Signifeye operates a network of 9 Belgian ophthalmology clinics on 15 locations, providing comprehensive eye care from routine consultations and diagnostics to advanced surgical procedures. Core services include cataract surgery, refractive surgery (SMILE-KLeX laser vision correction, ICL implantation, lens replacement), glaucoma diagnosis and treatment, retinal and corneal disease management, pediatric ophthalmology, oculoplastic/eyelid surgery, and dry-eye therapy. The group also acts as a buy-and-build platform that integrates independent eye clinics into the network while preserving their local brand identity.

Product overview

Signifeye is a network of ophthalmology clinics in Belgium, operating 9 clinics across 15 locations. As part of the international Optegra group (owned by EssilorLuxottica), Signifeye provides comprehensive eye care services through its member clinics. The network includes specialized clinics offering cataract surgery, refractive surgery (including SMILE laser treatments, ICL lens implantation, and lens replacement), retinal treatments, glaucoma care, corneal treatments, pediatric ophthalmology, and general eye care. Member clinics retain their individual identities while benefiting from shared knowledge, advanced technologies, and collaborative expertise across the network.

Differentiator

Problem solved

Functional benefit

Products and services

  • Signifeye Ophthalmology Clinic Network A network of 9 ophthalmology clinics on 15 locations across Belgium that delivers comprehensive eye care — from routine consultations and diagnostics to cataract surgery, refractive surgery, glaucoma, retina, cornea, pediatric ophthalmology, oculoplastic and dry-eye treatments — under a unified quality framework while preserving each clinic's local identity.
  • SMILE-KLeX Laser Vision Correction Advanced refractive surgery using the Zeiss Visumax 800 femtosecond laser to create and remove a precise corneal lenticule through a 2.5 mm incision, reshaping the cornea to correct myopia or, under SMILE-KLeX, hyperopia (with or without astigmatism).
  • Circle Post Hyperopic SMILE Pro Next-generation SMILE-KLeX technique for hyperopia incorporating a Circle component, enabling treatment of farsightedness in patients aged 20-50 with hyperopia from +1 to +5 diopters, potentially combined with astigmatism.
  • Oogcentrum Medipolis (Antwerp) Eye clinic in Antwerp founded by Dr. Erik Mertens, the first centre to join Signifeye in 2019; offers treatments to replace glasses and contact lenses, dry-eye treatment and other ophthalmology services for adult patients.
  • Oogartsen Regio Limburg (Maasmechelen, Hasselt-Kiewit, Diepenbeek) Multi-site ophthalmology practice across the Limburg region focusing on retinal diseases, contact lenses, low vision, eye prosthetics, dry eyes with IPL therapy and myopia control therapy.
  • Oogcentrum Brugge Bruges-based eye clinic with four doctors and seven staff, specializing in medical retina, eyelid surgery, tear duct surgery and general eye diseases.
  • Brussels Eye Doctors Brussels eye clinic specializing in corneal disease diagnosis and treatment, strabismus, pediatric eye diseases, tear duct disorders and retinal diseases and surgery; ISO 9001:2015 certified by Lloyd's Register Quality Assurance since June 2024.
  • Oogartsencentrum ZW-Vlaanderen & Kortrijk-West Ophthalmology center with locations in Harelbeke and Kortrijk-Bissegem, founded by Dr. Frank Kesteloot; a team of six ophthalmologists and four staff specializing in corneal and retinal disease (Kortrijk-West branch opened in 2024).
  • Oogartsenpraktijk Lier Lier-based ophthalmology practice founded by Dr. May Dieltiens, covering refractive surgery, strabismus and amblyopia, retinal abnormalities, glaucoma and corneal abnormalities.
  • Eyecenter Oogartsen (Sint-Martens-Latem, Eeklo, Merelbeke, Gavere) Large multi-site ophthalmology practice with eight ophthalmologists across four locations, founded by Dr. Fernand De Wilde; specializes in refractive surgery (SMILE laser, ICL lenses, lens exchange), cataract surgery, dry eyes, eyelid surgery, strabismus and age-related macular degeneration.
  • Oogkliniek Brasschaat Brasschaat-based eye clinic founded by Dr. Ann Haustermans, with five ophthalmologists and seven staff providing eye care to adults and children, including consultations, treatments, cataract surgery, refractive surgery and cosmetic eyelid surgery.
  • Brussels Eye Center Brussels eye clinic led by Dr. Jean Assaf with nine ophthalmologists, offering comprehensive eye care across general eye disease, cataracts, refractive surgery (laser, ICL, lens replacement), glaucoma, corneal disorders, strabismus, pediatric eye diseases, eyelid corrections, tear duct problems and retinal surgery.

Quantifiable outcome

  • First hyperopic SMILE procedure in Belgium and the Netherlands performed by Dr. Fernand De Wilde at Eyecenter, marking a world-first achievement in refractive surgery.
  • +2 more outcomes

Companies that use Signifeye

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Signifeye technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Signifeye partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • OptegracoreStrategic or Co-development Partner · 1 December 2025Signifeye is an integral part of Optegra, an international ophthalmology group with operations in the United Kingdom, the Netherlands, and several Central European countries. Optegra itself is owned by EssilorLuxottica. The partnership enables knowledge sharing across borders, access to best practices, shared technology investments, and a unified quality framework for clinical excellence.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Signifeye competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key highlights7 records

Customer concentration

Signifeye social profiles

Digital presence

Signifeye compliance and trust

Trust signal

Compliance1 record

Signifeye financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Signifeye leadership team

Management profile

Number of profiles

Profiles9 records

Signifeye subsidiaries and ownership

Company hierarchy

Subsidiaries9 records

Signifeye funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Signifeye M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Signifeye

What does Signifeye do?

Signifeye operates a network of 9 Belgian ophthalmology clinics on 15 locations, providing comprehensive eye care from routine consultations and diagnostics to advanced surgical procedures. Core services include cataract surgery, refractive surgery (SMILE-KLeX laser vision correction, ICL implantation, lens replacement), glaucoma diagnosis and treatment, retinal and corneal disease management, pediatric ophthalmology, oculoplastic/eyelid surgery, and dry-eye therapy. The group also acts as a buy-and-build platform that integrates independent eye clinics into the network while preserving their local brand identity.

Is Signifeye a public or private company?

Signifeye is a private company. It is classified as corporate owned and is currently operating.

When was Signifeye founded?

Signifeye was founded in 2019. It employs 1 to 10 people.

Where is Signifeye based?

Signifeye is headquartered in Antwerp, Belgium, in the Europe region.

How does Signifeye make money?

One revenue line is on record: ophthalmology Clinical Services.

Does Signifeye have an API?

No public API is recorded for Signifeye.

What industry is Signifeye in?

Signifeye's product category is Ophthalmology Services. Its primary akta.pro industry code is HLAKAKAC, Ophthalmology Clinics (Medical & Surgical Eye Care), with a secondary code of HLAKAKAB, Optometry Clinics (Primary Eye Care). Its NAICS code is 62132 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
WWDEssilorLuxottica Makes New Acquisition in Med-tech With Signifeye TakeoverEssilorLuxottica announced the acquisition of Signifeye, a Belgian ophthalmology platform operating 15 eye care centers in the Flanders region, with the transaction expected to close by the end of Q1 2026. This move expands EssilorLuxottica's med-tech division, complementing its recent takeover of Optegra and other medical technology assets. The company also reported strong financial performance for the first nine months of 2025, with revenues increasing 5.9% to 20.89 billion euros.MarketScreenerEssilorLuxottica to Buy Belgian Ophthalmology Firm SignifeyeEssilorLuxottica is set to acquire the Belgian ophthalmology firm Signifeye, enhancing its portfolio in vision care. This acquisition underscores EssilorLuxottica's commitment to integrating advanced technologies in eye health solutions. Such strategic moves might pave the way for further market expansion in the ophthalmology sector.InvestorshangoutEssilorLuxottica Expands Presence with Signifeye AcquisitionEssilorLuxottica has announced the acquisition of Signifeye, a Belgian ophthalmology platform operating 15 clinics and eye centers in Flanders, as part of its strategic expansion in the eye care sector.EuropaWireEssilorLuxottica Advances Med-Tech Ambitions with Addition of Belgian Ophthalmology Platform SignifeyeEssilorLuxottica has entered into an agreement to acquire Signifeye, a Belgian ophthalmology platform operating 15 eye centers and clinics across the Flanders region, with the transaction expected to close by Q1 2026. The acquisition follows the recent purchase of Optegra and supports EssilorLuxottica's broader med-tech strategy to build an integrated eye care model spanning prevention, diagnosis, and advanced treatment. Signifeye's clinical expertise and established reputation in private healthcare are expected to complement EssilorLuxottica's existing capabilities and expand its footprint in specialized eye care.MarketScreenerEssilorLuxottica Société anonyme (ENXTPA:EL) agreed to acquire Signifeye.EssilorLuxottica Société anonyme agreed to acquire Signifeye on December 12, 2025, with the transaction expected to close between January 1, 2026 and March 31, 2026. The acquisition represents EssilorLuxottica's continued expansion in the eyewear and optical industry, adding to its portfolio of lens technology and retail brands. Financial terms of the deal were not disclosed in the announcement.GlobeNewswireEssilorLuxottica to acquire Signifeye, further growing its ophthalmology clinics footprintEssilorLuxottica announced the acquisition of Signifeye, a leading Belgian ophthalmology platform operating 15 eye centers and clinics across the Flanders region, expected to close by Q1 2026. The transaction follows the recent Optegra acquisition and advances EssilorLuxottica's med-tech trajectory toward building an integrated medical model covering the full continuum of eye care from prevention to specialized clinical management. Signifeye's platform provides both medically necessary treatments and elective vision procedures, complementing Optegra's footprint of over 70 clinics across the UK, Czech Republic, Poland, Slovakia, and the Netherlands.EssilorluxotticaEssilorLuxottica to acquire Signifeye, further growing its ophthalmology clinics footprintEssilorLuxottica announced the acquisition of Signifeye, a Belgian ophthalmology platform operating 15 eye centers and clinics in the Flanders region, with the transaction expected to close by Q1 2026. The deal follows the recent acquisition of Optegra, another European ophthalmology platform with over 70 clinics across the UK, Czech Republic, Poland, Slovakia, and the Netherlands. The acquisition advances EssilorLuxottica's med-tech trajectory and its ambition to build an integrated eye care model spanning prevention to specialized clinical management.MorningstarEssilorLuxottica Snaps Up Belgium's SignifeyeEssilorLuxottica has agreed to acquire Belgian ophthalmology platform Signifeye, which operates 15 centers and clinics across Belgium's Flanders region. The transaction is expected to close in the first quarter of next year, though financial terms were not disclosed. The deal follows EssilorLuxottica's recent acquisition of Optegra, another European ophthalmology platform, as the Ray-Ban maker expands its medical portfolio toward delivering end-to-end eye care.YahooFrench luxury group Kering buys sun lens maker Lenti from Italy's SafiloEssilorLuxottica announced the acquisition of Signifeye, a Belgian ophthalmology platform operating 15 eye care centers in the Flanders region, to expand its med-tech division. This transaction follows a series of recent acquisitions including Optegra and Espansione Group, reinforcing the company's strategy for end-to-end eye care services. The deal is expected to close by the end of the first quarter of 2026.